Health Committee Republicans Request Details On FDA’s Promotion Of The New Health Care Law

Wednesday, June 19, 2013

All Republican members of the Senate health committee on Wednesday sent a letter to U.S. Food and Drug Administration (FDA) Commissioner Margaret Hamburg requesting details on the agency’s promotion of the new health care law, saying, “The upcoming enrollment period and coverage availability under PPACA appear to be outside of your agency’s mission to approve and regulate lifesaving medical products in a timely manner and keeping our food supply safe."

Senator Lamar Alexander (R-Tn.), the committee’s lead Republican, along with Senators Mike Enzi (R-Wyo.), Richard Burr (R-N.C.), Johnny Isakson (R-Ga.), Rand Paul (R-Ky.), Orrin Hatch (R-Utah), Pat Roberts (R-Kan.), Lisa Murkowski (R-Ak.), Mark Kirk (R-Il.), and Tim Scott (R-S.C.) sent the letter in response to an email alert issued through the FDA’s public email distribution system that promoted open enrollment in the new health insurance exchanges—offering links to a free webinar and promoting the benefits of the law to four different groups: families, individuals, small businesses and clinicians. For example, for clinicians the email detailed “the top five ways you and your practice benefit from the Affordable Care Act.”

The senators wrote: “We are writing to ask why and under what authority the Food and Drug Administration (FDA) is using its time and resources to enroll Americans in health insurance marketplaces created by the new health care law.  On June 3, 2013, the FDA sent a notice to families, individuals, small businesses and clinicians promoting insurance market changes in the new health care law. The e-mail alerts your agency sends to the public should reflect your agency’s actual statutory mission to assure the safety of food, drugs, and medical devices.  The upcoming enrollment period and insurance coverage availability under the new law appear to be outside of your agency’s mission to approve and regulate lifesaving medical products in a timely manner and keeping our food supply safe.”

They added: “In light of the current fiscal environment and recent sequestration, it is especially important to focus scarce resources on FDA’s actual mission. You have said publicly that under the sequester, ‘Clearly we will be able to provide less of the oversight functions and we won't be able to broaden our reach to new facilities either, so inevitably that increases risk.’”

They continued: “While our nation suffers from numerous drug shortages and patients are waiting for drugs and medical device approvals, the FDA should not be using resources designated for these purposes to fund an effort unrelated to your agency’s mission of ‘assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.’ We are also concerned that this is another attempt by the Department of Health and Human Services to avoid congressional limitations on implementation expenditures for the new health care law.”

The full text of the letter is below:

The Honorable Margaret Hamburg

Commissioner

U.S. Food and Drug Administration

10903 New Hampshire Avenue

Silver Spring, MD 20093

Dear Commissioner Hamburg:

We are writing to ask why and under what authority the Food and Drug Administration (FDA) is using its time and resources to enroll Americans in health insurance marketplaces created by the new health care law.  On June 3, 2013, the FDA sent a notice to families, individuals, small businesses and clinicians promoting insurance market changes in the new health care law. The e-mail alerts your agency sends to the public should reflect your agency’s actual statutory mission to assure the safety of food, drugs, and medical devices.  The upcoming enrollment period and insurance coverage availability under the new law appear to be outside of your agency’s mission to approve and regulate lifesaving medical products in a timely manner and keeping our food supply safe.

In light of the current fiscal environment and recent sequestration, it is especially important to focus scarce resources on FDA’s actual mission. You have said publicly that under the sequester, “Clearly we will be able to provide less of the oversight functions and we won't be able to broaden our reach to new facilities either, so inevitably that increases risk."[1]

While our nation suffers from numerous drug shortages and patients are waiting for drugs and medical device approvals, the FDA should not be using resources designated for these purposes to fund an effort unrelated to your agency’s mission of “assuring the safety, efficacy and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation.”   We are also concerned that this is another attempt by the Department of Health and Human Services to avoid congressional limitations on implementation expenditures for the new health care law. 

For these reasons, we would like to know:

1.       Under what legal authority is your agency promoting implementation of the new health care law and/or insurance coverage?

2.       How do your activities further the mission of the Food and Drug Administration?

3.       In addition to the attached email, what additional activities is FDA undertaking to support implementation of the new healthcare law?

4.       What appropriations account is FDA charging for its costs in supporting implementation of the new healthcare law?

5.       What are the total costs to date and what is the amount allocated for the fiscal year for these activities?

Please respond in writing no later than June 26, 2013.

Sincerely,

Lamar Alexander, Ranking Member

Mike Enzi

Richard Burr

Johnny Isakson

Rand Paul

Orrin Hatch

Pat Roberts

Lisa Murkowski

Mark Kirk

Tim Scott

cc:        The Honorable Daniel Levinson, Inspector General

            The Honorable Gene Dodaro, Comptroller General


Shaw Receives St. Jude 2017 Proprietary Campaign Of The Year Award

Shaw Industries Group, Inc. has been selected as the recipient of the St. Jude Children’s Research Hospital 2017 Proprietary Campaign of the Year award. This award issued by St. Jude recognizes a corporate partner who has implemented a successful proprietary campaign in addition to their primary means of support for the hospital. Shaw’s collective efforts around its cushion and ... (click for more)

Free Smoking Cessation Courses Begin In May And June Around Chattanooga Area

CHI Memorial Medical Group practices offer a free eight-session Freedom From Smoking program which helps participants learn how to beat tobacco addiction, lifestyle changes that make quitting easier, stress management, how to avoid weight gain, and how to stay smoke-free for good.   Freedom From Smoking is an American Lung Association program that has helped more than one ... (click for more)

Valerie Bray To Serve Workhouse Time For Traffic Death Of Runner Cameron Bean

Criminal Court Judge Tom Greenholtz on Thursday ordered that Valerie Bray serve 11 months and 29 days in the workhouse for the   Sept. 19, 2015, traffic death of runner Cameron Bean at Moccasin Bend. She was given concurrent two-year sentences for criminally negligent homicide and leaving the scene of an accident. She faced 1-2 years on each count. The state had not ... (click for more)

Law Enforcement Shuts Down Convenience Store Near College Hill Courts As Public Nuisance

Law enforcement on Thursday took steps to shut down a convenience store near the College Hill Courts as a public nuisance. The action was taken after District Attorney Neal Pinkston filed a petition with Criminal Court Judge Tom Greenholtz about the Westside Shop. The store is operated by Salma Ambo, and the real property is owned by AAA Investment Properties LLC. The petition ... (click for more)

White Coat Syndrome And The Medical System - And Response

Today I wish to share what I am feeling as a patient in our medical system. I am too old to put on airs at this point, and this is too pervasive of a problem for me to contain.   As I enter my AARP years, I am faced with so many medical encounters that evoke all kinds of uncomfortable feelings. I dread physician’s appointments riddled with government regulatory hypocrisy, ... (click for more)

Roy Exum: Knoxville’s Godsend

Back when we were uppity teenagers, the best put-down when a friend started acting crazy was to say to the heathen, “Quit acting like you are from Knoxville!” I don’t know how the term originated but I can say that back in the day it was pretty insulting to be told you were acting like you were from Knoxville. This week I wish that more of us acted like Knoxville. The Knox County ... (click for more)